The following data is part of a premarket notification filed by Civatech Oncology, Inc. with the FDA for Civastring Pd-103.
Device ID | K082159 |
510k Number | K082159 |
Device Name: | CIVASTRING PD-103 |
Classification | Source, Brachytherapy, Radionuclide |
Applicant | CIVATECH ONCOLOGY, INC. 1317 BUCHANAN DR. Mebane, NC 27302 |
Contact | Lois V Smart |
Correspondent | Lois V Smart CIVATECH ONCOLOGY, INC. 1317 BUCHANAN DR. Mebane, NC 27302 |
Product Code | KXK |
CFR Regulation Number | 892.5730 [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Traditional |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 2008-07-31 |
Decision Date | 2008-09-30 |
Summary: | summary |
Device Identifier | submissionNumber | Supplement |
---|---|---|
00869497000104 | K082159 | 000 |